Browse All

Current Filters

CLEAR FILTER x

TITLE

ND0612 Infusion Dramatically Reduces OFF-time and Improves Quality of Life in Parkinson’s Disease: A Meta-analysis of Randomized Trials

Author:Lin, Shenney   Pitton Rissardo, Jamir   Elmandouh, Omar   Fornari Caprara, Ana Leticia   Walker, Ian M.   

Session Name:P8: Movement Disorders: Parkinson's Disease Emerging Therapeutics 2  

Topic:Movement Disorders  

Program Number:P8.009  

Author Institution:Cooper Medical School of Rowan University, NJ  Cooper University Hospital, Camden, NJ  Cooper University Hospital, NJ  

Phase One Study of BT-267: A Potent, Selective, Brain-penetrant, and Oral Small Molecule Inhibitor of LRRK2

Author:Dam, Tien   Dokukina, Kate   Remeeva, Eugenia   Kazey, Vasily   Karapetian, Ruben   Pushechnikov, Alexei   Mathias, Anita   Marvasty, Idean   Savchuk, Nikolay   Dukes, Iain   Hilt, Dana   

Session Name:P8: Movement Disorders: Parkinson's Disease Emerging Therapeutics 2  

Topic:Movement Disorders  

Program Number:P8.010  

Author Institution:Brenig Therapeutics, Dover, DE  Brenig Therapeutics, DE  Brenig Therapeutics, Lamoine, ME  

Clinical and Immunologic Safety Evaluation of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Parkinson’s Disease

Author:Onuigbo, Chiamaka   Saltarrelli, Jerome   Martinez Lemus, Juan   Tharp, Emily   Olson, Scott   Triolo, Fabio   Bianchi, Joana   Ritter III, Robert   Schiess, Mya   

Session Name:P8: Movement Disorders: Parkinson's Disease Emerging Therapeutics 2  

Topic:Movement Disorders  

Program Number:P8.011  

Author Institution:University of Texas Health Sciences Center at Houston, TX  University of Texas Health Sciences Center at Houston, Houston, TX  

Mechanism of Action, Preclinical Efficacy, and Safety Evaluation of ACP-711 (SAN711): A Novel GABAA Subunit a3 Selective Modulator

Author:Amrutkar, Dipak V.   Sandager-Nielsen, Karin   Dyhring, Tino   Jacobsen, Thomas Amos   Larsen, Janus S.   Muglia, Pierandrea   Pathak, Sanjeev   Lin, Hank   Hofbauer, Robert   

Session Name:P8: Movement Disorders: Parkinson's Disease Emerging Therapeutics 2  

Topic:Movement Disorders  

Program Number:P8.012  

Author Institution:Saniona A/S, Glostrup, Denmark  Acadia Pharmaceuticals, Inc., Princeton, NJ  Acadia Pharmaceuticals, Inc., San Diego, CA  

Fecal Microbiota Transplantation in Parkinson's Disease: A Systematic Review, Meta-analysis, and Meta-regression

Author:Tudella, Gabriel   Machado Pereira, Maria Antonia   Klostermann, Augusto   Ohannesian, Victor Arthur   Golçalves, Ocílio   Silva, Rebeca   Fernandes, João Vitor   Ahmed, Adil   Alencar, Ana Beatriz   Morais, Sandra   Almeida, Kelson   

Session Name:P8: Movement Disorders: Parkinson's Disease Emerging Therapeutics 2  

Topic:Movement Disorders  

Program Number:P8.014  

Author Institution:Federal University of Santa Maria, Santa Maria, Brazil  State University of Piauí, Teresina, Brazil  Federal University of Santa Maria, Brazil  Hospital Israelita Albert Einsten, São Paulo, Brazil  Federal University of Piauí, Brazil  Federal University of Paraíba, João Pessoa, Brazil  Federal University of Paraíba, Cabedelo, Brazil  Northwest School of Medicine, Peshawar, Pakistan  Afya Uninovafapi University Center, Brazil  Federal University of Piauí, Teresina, Brazil